FAST BioMedical Announces Successful Completion of Open-Label Proof-of-Concept Study for Measuring Interstitial Volume

FAST BioMedical, a privately held, late-clinical-stage medical technology company, today announces the completion of an open-label study using its technology in chronic dialysis patients.

Sensyne Health Signs First US Strategic Research Agreement with St. Luke’s University Health Network

Sensyne Health Signs First US Strategic Research Agreement with St. Luke’s University Health Network

MicrobioSeq Introduces Microbial Iso-Seq to Characterize the Diverse Landscape of Transcript Isoforms

Bioinformatics-Analysis Division of CD Genomics Introduces Single Cell Genome Analysis Services

Rousselot® Biomedical launches X-Pure® GelDAT, first ever purified and phenol-functionalized gelatin

Rousselot®, a brand of Darling Ingredients, and the global leader of collagen-based solutions1 expands its range of purified, pharmaceutical grade, modified gelatins with the launch of X-Pure® GelDAT – Gelatin Desaminotyrosine. Created in response to customers' demands to overcome the barriers encountered in clinic translation, this is the first readily available biomaterial of its kind. X-Pure® GelDAT offers guaranteed purity and consistency at scale, vital to the successful development of biomedical applications used in the human body.

Sharp Appoints New Leader to its Global Clinical Services Business

MedPharm, Ltd Upgrades and Expands Its Formulation Development Labs, Analytical Labs and Clinical Manufacturing Suites in the United Kingdom

MedPharm announces complete refurbishment and modernization of its 15,000 sq ft campus in Surrey, UK.

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine

The agreement will further enable global supply of mRNA-1273, Moderna’s COVID-19 vaccine with Samsung Biologics’ fill and finish manufacturing service

Charles Fracchia selected for DARPA ISAT Study Group

GutFlora Omics Platform Announces Solutions for Gut Microbiota Related Mental Disorder

VERICHEM LABORATORIES OFFERS LIQUID STABLE, NIST TRACEABLE, COMBINED CHOLESTEROL/URIC ACID STANDARD REFERENCE KIT

The liquid stable and ready-to-use MATRIX PLUS™ Cholesterol Reference Kit, containing known concentrations of both Cholesterol and Uric Acid and expressly designed to support overall system QC and CLIA compliance, is now available from VERICHEM LABORATORIES.

Creative Enzymes Launches Advanced Neuraminidase for Flu Vaccine Development

The Jewish General Hospital and the CIUSSS du Centre-Ouest-de-l’Ile-de-Montréal Partner with MDClone to Deliver Better Data-Driven Care for Patients

US Orthopedic Alliance Selects 2bPrecise to Accelerate Precision Medicine Program

US Orthopedic Alliance (USOA) selected 2bPrecise to provide its precision medicine platform to USOA’s network of more than 100 orthopedic surgeons.

Sensyne Health Signs Strategic Research Agreement with the Colorado Center for Personalized Medicine

Pronalyse's Comprehensive Biosimilar Analysis Solutions Support Your Drug Discovery

ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers

The collaboration will improve visibility and reporting of cell and gene therapy manufacturing through a pre-integrated data solution

News Update: MedAI Integrates AIDD Platform, CADD Platform, and Experimental Validation Platform for Drug Discovery

Earlier this month, MedAI announces that it has integrated its three AI-powered drug discovery platforms so as to increase drug candidate efficacy and safety throughout the preclinical research. Previously, the company has released AIDD Platform, CADD Platform, and Experimental Validation Platform, which consist of proprietary hardware, biological, molecular and digital technologies.

VERICHEM LABORATORIES OFFERS FREE CLIA COMPLIANT, WEB-BASED CALIBRATION VERIFICATION DATA REDUCTION SERVICES

VERICHEM now furnishes all customers free access to the company’s online, web-based, data reduction services, designed specifically for use with the company's broad line of clinical reference materials,

Alfa Chemistry Released Four Types of Featured Products for the Research Community

In an effort to combine what the customers truly need and what the company provides, Alfa Chemistry recently sorted and released four types of featured products for scientists and researchers who are engaged with the tumor, coronavirus, and flu treatment research as well as the production of personal daily care products.